A modest proposal for a new way forward for clinical research: Involve insurance companies.
James H ClarkJayant M PintoRobert M NaclerioPublished in: International forum of allergy & rhinology (2022)
Is it time for medical insurance companies to organize and fund clinical research that evaluates the role of new treatments (drugs or device-based therapies) in the context of existing clinical paradigms for common diseases?